Literature DB >> 17056577

CD43 deficiency has no impact in competitive in vivo assays of neutrophil or activated T cell recruitment efficiency.

Douglas A Carlow1, Hermann J Ziltener.   

Abstract

Using noncompetitive methodologies comparing CD43(+/+) and CD43(-/-) mice, it has been reported that CD43(-/-) leukocytes exhibit reduced recruitment efficiency to sites of inflammation. More recent analyses demonstrate that CD43 on activated T cells can function as an E-selectin ligand (E-SelL) in vitro, suggesting that CD43 might promote rolling interactions during recruitment of leukocytes and account for the reported recruitment deficits in CD43(-/-) T cells and neutrophils in vivo. Internally controlled competitive in vivo methods using fluorescent tracking dyes were applied to compare recruitment efficiency of CD43(+/+) vs CD43(-/-) activated T cells to inflamed skin and of peripheral blood neutrophils to inflamed peritoneum. A simple CFSE perfusion method was developed to distinguish arterial/venous vasculature and confirm appropriate extravasation through venules in a Con A-induced cutaneous inflammation model. In vivo recruitment of peripheral blood neutrophils to inflamed peritoneum was core 2 GlcNAcT-I dependent, but recruitment efficiency was not influenced by absence of CD43. There were also no significant differences in core 2 GlcNAcT-I-dependent, selectin-dependent, cutaneous recruitment of activated T cells from CD43(+/+) and congenic CD43(-/-) mice in either B6 or P-selectin(-/-) recipients despite biochemical confirmation that a CD43-specific E-SelL was present on activated T cells. We conclude that recruitment of neutrophils and activated T cells in these in vivo models is not influenced by CD43 expression and that if CD43 on activated T cells performs an E-SelL function in vivo, it contributes in a limited physiological context.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056577     DOI: 10.4049/jimmunol.177.9.6450

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.

Authors:  Alexander Zarbock; Klaus Ley; Rodger P McEver; Andrés Hidalgo
Journal:  Blood       Date:  2011-10-20       Impact factor: 22.113

Review 2.  E-selectin ligands as mechanosensitive receptors on neutrophils in health and disease.

Authors:  S D Chase; J L Magnani; S I Simon
Journal:  Ann Biomed Eng       Date:  2012-01-24       Impact factor: 3.934

3.  Signaling through CD43 regulates CD4 T-cell trafficking.

Authors:  Purvi D Mody; Judy L Cannon; Hozefa S Bandukwala; Kelly M Blaine; Alexander B Schilling; Kevin Swier; Anne I Sperling
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

4.  Core 1-derived O-glycans are essential E-selectin ligands on neutrophils.

Authors:  Tadayuki Yago; Jianxin Fu; J Michael McDaniel; Jonathan J Miner; Rodger P McEver; Lijun Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

5.  Mucin O-glycan branching enzymes: structure, function, and gene regulation.

Authors:  Pi-Wan Cheng; Prakash Radhakrishnan
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 6.  Glycosyltransferases, glycosylation and atherosclerosis.

Authors:  Qianghong Pu; Chao Yu
Journal:  Glycoconj J       Date:  2014-10-08       Impact factor: 2.916

Review 7.  Glycosylation in immune cell trafficking.

Authors:  Markus Sperandio; Christian A Gleissner; Klaus Ley
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

8.  An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation.

Authors:  Akiko Shigeta; Masanori Matsumoto; Thomas F Tedder; John B Lowe; Masayuki Miyasaka; Takako Hirata
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

9.  CD43 regulates Th2 differentiation and inflammation.

Authors:  Judy L Cannon; Amélie Collins; Purvi D Mody; Diwaker Balachandran; Kammi J Henriksen; Cassandra E Smith; Jiankun Tong; Bryan S Clay; Stephen D Miller; Anne I Sperling
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.

Authors:  Francisco Velázquez; Anna Grodecki-Pena; Andrew Knapp; Ane M Salvador; Tania Nevers; Kevin Croce; Pilar Alcaide
Journal:  J Immunol       Date:  2015-12-23       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.